The £1.9bn biotech investor says the 'malaise’ that has hung over the sector since Covid has evaporated, while the board defends itself.
Michelle McGagh is a news reporter for Citywire, covering a wide range of financial and investment topics. With a focus on providing expert views and analysis, Michelle delivers articles on stock market updates, company performances, and economic indicators. Her reporting aims to provide valuable insights for investors and individuals interested in the financial sector.